Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+57.7%
5Y CAGR+126.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+57.7%/yr
Annual compound
5Y CAGR
+126.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
59.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $47.04M | +48.5% |
| 2024 | $31.68M | +105.9% |
| 2023 | $15.38M | +28.2% |
| 2022 | $12.00M | +67.3% |
| 2021 | $7.17M | +810.9% |
| 2020 | $787499.00 | - |